Hyperthermia and ablation system developer BSD Medical saw revenues for its third quarter of fiscal 2012 nosedive compared to the same period in 2011. The company attributed the situation to the global economic downturn and the sale of fewer hyperthermia systems.
BSD reported third-quarter revenue of $651,000 for the three months ended May 31, 2012, compared with $1.7 million a year ago. Total revenue for the fiscal year to date reflects a similar dip, at $1.6 million for the nine-month period, compared with total revenue of $2.6 million for the same period in 2011.
The company had a net loss of $2.1 million in the third quarter, with a loss of $5.9 million for the nine months ended May 31.
